Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

The pizza box problem — and why it might kill everything from Teflon to drugs

By Paul Heney | April 26, 2023

By Mark Jones

It looks innocuous in my hand, yet there are growing calls to ban it. It may use technology created for the Manhattan Project, but, in my hand, it doesn’t feel like a weapon. It feels natural, in spite of the very unnatural materials it may contain. I’m not at all cautious as I open it. Reaching in, I grab a slice. I do love pizza.

Pizza predates the Manhattan Project. Although pizza technically isn’t the problem, it’s the box. Cardboard for pizza boxes have been made resistant to both grease and steam using fluorocarbons. Five years ago, almost certainly, per- or polyfluorinated alkyl substances, PFAS, would have been used. Some states have now banned PFAS in things like pizza boxes. I’m not in one of those states. I can’t be sure whether the box in my hand uses PFAS or not.

PFASes were initially identified as a health concern at hotspots. There are many maps with markers locating these hotspots contaminated most commonly by some intense use of PFAS in manufacturing or firefighting. Realization of widespread contamination from use in paper may ultimately be the trigger for bans gaining traction.

Check out the full article at R&D World


Filed Under: RD, Regulatory affairs
Tagged With: ban, contamination, environmental impact, fluorocarbons, functionalized fluorocarbons, health concerns, oxidizing titration, PFAS, polymers, risks, synthetic materials
 

Related Articles Read More >

M&A Merger and acquisition business finance concept. Businessman pressing button.
25-plus years of Big Pharma megadeals
pharma R&D | molecule model
Are Big Pharma giants getting the right ROI on their R&D investments? A visual exploration
Cleveland
Ohio grows into a globally recognized R&D hub
Pharma's top 20 R&D spenders in pharma in 2021
Pharma’s top 20 R&D spenders in 2021
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE